- Home
- GBLI vs OABI Comparison
GBLI vs OABI Comparison
Compare GBLI & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GBLI | OABI |
|---|---|---|
| Founded | 2016 | 2012 |
| Country | United States | United States |
| Employees | N/A | 89 |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 395.4M | 391.4M |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | GBLI | OABI |
|---|---|---|
| Price | $25.03 | $2.51 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.50 |
| AVG Volume (30 Days) | 5.3K | ★ 517.1K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 5.13% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.29 | N/A |
| Revenue | ★ $450,098,000.00 | N/A |
| Revenue This Year | $14.23 | $52.42 |
| Revenue Next Year | $9.68 | $64.69 |
| P/E Ratio | $85.08 | ★ N/A |
| Revenue Growth | ★ 2.02 | N/A |
| 52 Week Low | $24.28 | $1.32 |
| 52 Week High | $34.00 | $2.79 |
Technical Indicators
Market Signals| Indicator | GBLI | OABI |
|---|---|---|
| Relative Strength Index (RSI) | 35.32 | 58.94 |
| Support Level | N/A | $1.42 |
| Resistance Level | $29.07 | $2.79 |
| Average True Range (ATR) | 0.73 | 0.20 |
| MACD | -0.09 | -0.02 |
| Stochastic Oscillator | 29.05 | 75.00 |
Price Performance
Historical ComparisonAbout GBLI Global Indemnity Group LLC (DE)
Global Indemnity Group LLC is a United States-based holding company with a diversified portfolio of property and casualty insurance-related entities. Along with its subsidiaries, the company operates in the following reportable segments: Agency and Insurance Services, Belmont Insurance Companies - Core (Belmont Core), and Belmont Insurance Companies - Non-Core (Belmont Non-Core). Maximum revenue is generated from the Belmont Core segment, which offers direct insurance and assumed reinsurance products in the E&S (Excess and Surplus) marketplace. The Agency and Insurance Services segment is focused on sourcing, underwriting, and servicing primary and assumed reinsurance business; and specialized insurance service businesses providing technology, AI-enabled marketplace, and claims services.
About OABI OmniAb Inc.
OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.